These findings confirm that M1-like macrophages might activate HMGB1 signaling to induce cardiac inflammation in EAM rats, and that treatment with the small molecule Gβγ inhibitor gallein can modulate this signaling pathway in EAM rats. The gene discussed is HMGB1; the disease is inflammatory response.